---
title: "SBT's net profit for the year 2024 is 84.7591 million yuan, a year-on-year increase of 27.37%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227201818.md"
description: "SBT released its 2024 annual performance report, with operating revenue of 583 million yuan, a year-on-year increase of 11.03%; net profit of 84.7591 million yuan, a year-on-year increase of 27.37%. Operating profit increased by 30.68% year-on-year, mainly benefiting from the bulk shipment of harness connectors, semiconductor equipment, growth in accessory revenue, asset disposal gains, and government subsidies"
datetime: "2025-02-05T11:11:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227201818.md)
  - [en](https://longbridge.com/en/news/227201818.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227201818.md)
generator: "portal-rs"
---

# SBT's net profit for the year 2024 is 84.7591 million yuan, a year-on-year increase of 27.37%

According to the Zhitong Finance APP, SBT (688392.SH) disclosed its performance report for the year 2024. During the reporting period, the company achieved operating revenue of 583 million yuan, an increase of 11.03% compared to the same period last year; the net profit attributable to the owners of the parent company was 84.7591 million yuan, an increase of 27.37% compared to the same period last year.

During the reporting period, operating profit increased by 30.68% year-on-year, mainly due to the bulk shipment of equipment in the fields of harness connectors and semiconductors, growth in accessory revenue, gains from asset disposals, and government subsidies received

### Related Stocks

- [688392.CN](https://longbridge.com/en/quote/688392.CN.md)
- [688409.CN](https://longbridge.com/en/quote/688409.CN.md)
- [CP00062.US](https://longbridge.com/en/quote/CP00062.US.md)
- [SOXX.US](https://longbridge.com/en/quote/SOXX.US.md)
- [002371.CN](https://longbridge.com/en/quote/002371.CN.md)
- [688012.CN](https://longbridge.com/en/quote/688012.CN.md)
- [SOXS.US](https://longbridge.com/en/quote/SOXS.US.md)
- [SOXL.US](https://longbridge.com/en/quote/SOXL.US.md)

## Related News & Research

- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)
- [Why the AI boom has become an election problem](https://longbridge.com/en/news/297766132.md)
- [Nutra Pharma says Pure Raw Supplies gains control with 62.63% voting power after Series B transfer](https://longbridge.com/en/news/297819211.md)
- [06:50 ETUnited Imaging secures CE mark for world's first dual wide-coverage CT family](https://longbridge.com/en/news/297901060.md)
- [Asker Healthcare agrees to buy Poland medical equipment distributor Labo Clinic](https://longbridge.com/en/news/297879779.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**